Reduced Toxicity, Myeloablative Conditioning With BU, Fludarabine, Alemtuzumab and SCT From Sibling Donors in Children With Sickle Cell Disease
Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2014.84
Full Text
Open PDFAbstract
Available in full text
Date
May 5, 2014
Authors
Publisher
Springer Science and Business Media LLC